ANV-221

N/A

Report date: 2025/01/26 18:39:14
NME

Base Information

Drug NameANV-221
Drug Alias NameAminouridyl phenoxypiperidinbenzyl butamideGlycosylation (Anviron Corporation)ANV-221
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycosylation modulators
TargetsUpdating
Therapy Area/IndicationsPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAnviron Corp
China Registration ClassN/A

Develop Information

Active CompaniesAnviron Corp
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A